MONEY

Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 23, 2024 - 20:00
Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
Read More

Tags:

Previous Article

VitalHub Announces Strategic Hire to Accelerate Corporate Growth

Next Article

Intel, Constellation Energy and Trump Media rise premarket; GM and Nike fall

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

After downgrading Amazon, Wells Fargo says buy Microsoft stock

After downgrading Amazon, Wells Fargo says buy Microsof...

Tomas Kauer - Mode... Oct 8, 2024

Nb Bancorp EVP acquires $9.4k worth of company stock

Nb Bancorp EVP acquires $9.4k worth of company stock

Tomas Kauer - Mode... Sep 21, 2024

Peter Thiel sells over $457 million in Palantir Technologies stock

Peter Thiel sells over $457 million in Palantir Technol...

Tomas Kauer - Mode... Oct 2, 2024